Skip to content

The efficacy of ramelteon to prevent postoperative delirium after general anesthesia in the elderly: a randomized placebo controlled trial

The efficacy of ramelteon to prevent postoperative delirium after general anesthesia in the elderly: a randomized placebo controlled trial - The efficacy of ramelteon to prevent postoperative delirium after general anesthesia in the elderly: a randomized placebo controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000028436
Enrollment
108
Registered
2017-07-29
Start date
2017-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium

Interventions

Patients take 8 mg ramelteon for six nights, preoperative night and consecutive 5 nights, beginning on postoperative day 1. Patients take matching lactose for six nights, preoperative night and consec

Sponsors

Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists physical status 1,2,or 3 and scheduled to undergo general surgery, urological surgery, vascular surgery, or chest surgery under general anesthesia.

Exclusion criteria

Exclusion criteria: Patients who are delirious on registry Patients who are currently taking ramelteon Patients who have a previous adverse reaction to ramelteon Patients who take medicine contraindicated to be coadministered with ramelteon Patients with lactose intolerance Patients who are considered non per os on postoperative day 1 Patients who are considered to be discharged within postoperative day 6 Patients who have a score less than or equal to 10 on the Mini Mental State Examination Patients who have severe hepatic damage Patients with known Dementia with Lewy bodies

Design outcomes

Primary

MeasureTime frame
The difference in the incidence of delirium as determined by Diagnostic and Statistical Manual of Mental Disorders, version 5 criteria between the placebo and ramelteon groups from postoperative day 0 to 6

Countries

Japan

Contacts

Public ContactMariko Mariko

Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology Department of Anesthesiology

mariko2390@yahoo.co.jp03-3964-1141

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026